Why the study?
Does captopril alter ACE activity and concentration in serum, lungs, and kidneys in normotensive Wistar rats?
Does captopril alter ACE activity and concentration in serum, lungs, and kidneys in normotensive Wistar rats?
Captopril treatment in rats induces dynamic, dose-dependent changes in ACE activity and concentration across serum, lung, and kidney tissues, suggesting compensatory ACE biosynthesis.
No immediate implications for human ACE inhibitor use; leaves open compensatory ACE regulation in disease models.
The effect of treatment time and dose of captopril with regard to angiotensin converting enzyme (ACE) in serum, lungs and kidneys of the rat were studied. Normotensive Wistar rats were treated with a constant dose of captopril (0.2 mg/ml) during various time periods. In a second study rats were treated with different captopril doses (6.25 micrograms, 12.5 micrograms, 25 micrograms, 50 micrograms, and 200 micrograms/ml water) during three weeks. Serum ACE activity and pulmonary and kidney plasma membrane ACE concentrations were measured in both studies. Captopril treatment resulted in a rapid decrease of ACE in pulmonary and kidney plasma membranes and a simultaneously increase of serum ACE activity during the first day of treatment. This was followed by increased membrane concentrations of ACE in the lungs and return to normal ACE concentrations in membranes of kidneys, presumably due to increased ACE biosynthesis. Serum ACE activity continued to increase during the whole study. Serum ACE activity increased in a dose dependent manner during treatment with different captopril doses. Increased plasma membrane ACE concentrations were not observed in the rats treated with captopril at doses below 200 micrograms/ml water.
No takes yet. Share an insight, caveat, or question.
Terje Forslund (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: